Injectable treatments remain the cornerstone of aesthetic medicine, and yet our understanding of them continues to evolve. What we thought we knew about dermal filler behavior, combination strategies, and tailoring injection technique to different anatomic sites has changed dramatically, even in the past few years.
Ultrasound imaging has enabled real-time observation of filler placement, and the resulting picture is more nuanced than the old model of static, contained volume. We have learned that product spreads predictably along tissue planes and follows the path of least resistance; this knowledge now informs our placement strategies.
Precision also increasingly drives how aesthetic clinicians approach patient concerns and combination treatment. A detailed facial assessment, rather than a reflexive reach for volume, is becoming the standard for addressing patient hesitation about looking “overdone.” We are also layering modalities deliberately—pairing hyaluronic acid gel with biostimulatory filler, for instance—to capture both immediate and long-term benefit in a single visit, rather than treating each product as an isolated treatment. Similar logic extends to skin boosters, which are now another pillar of injectable treatment alongside neuromodulator, hyaluronic acid gel filler, and biostimulatory filler, built to address skin quality rather than movement or volume.
None of this represents a departure from injectables. These developments indicate an evolving specialty becoming more exact about what each treatment addresses, which patient it best suits, and how it complements everything else in our armamentarium. That is the throughline of this issue, and it is why injectable treatments remain as central to this specialty as they have ever been.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
